180 related articles for article (PubMed ID: 16729871)
1. Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Nadar SK; Tayebjee MH; Messerli F; Lip GY
Curr Pharm Des; 2006; 12(13):1581-92. PubMed ID: 16729871
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of target organ damage in hypertension.
Karpha M; Lip GV
Minerva Cardioangiol; 2006 Aug; 54(4):417-29. PubMed ID: 17016413
[TBL] [Abstract][Full Text] [Related]
3. Association between left ventricular hypertrophy with retinopathy and renal dysfunction in patients with essential hypertension.
Shirafkan A; Motahari M; Mojerlou M; Rezghi Z; Behnampour N; Gholamrezanezhad A
Singapore Med J; 2009 Dec; 50(12):1177-83. PubMed ID: 20087555
[TBL] [Abstract][Full Text] [Related]
4. Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study.
Oladapo OO; Salako L; Sadiq L; Shoyinka K; Adedapo K; Falase AO
Cardiovasc J Afr; 2012 Aug; 23(7):379-84. PubMed ID: 22914995
[TBL] [Abstract][Full Text] [Related]
5. Cumulative Effects of Several Target Organ Damages in Risk Assessment in Hypertension.
Harbaoui B; Courand PY; Defforges A; Khettab F; Milon H; Girerd N; Lantelme P
Am J Hypertens; 2016 Feb; 29(2):234-44. PubMed ID: 26112867
[TBL] [Abstract][Full Text] [Related]
6. Characteristic abnormal findings of ambulatory blood pressure indicative of hypertensive target organ complications.
Tseng YZ; Tseng CD; Lo HM; Chiang FT; Hsu KL
Eur Heart J; 1994 Aug; 15(8):1037-43. PubMed ID: 7988594
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological characteristics of subclinical target organ damage in urban adult residents with hypertension in Tianjin and its relationships with renin-angiotensin-aldosterone system].
Li YL; Wan Z; Sun YM; Lu WL; Yao W; Yu XF; Wang Y; Wang JH
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):415-9. PubMed ID: 21418917
[TBL] [Abstract][Full Text] [Related]
8. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
[TBL] [Abstract][Full Text] [Related]
9. Target organ damage and associated clinical conditions among Nigerians with treated hypertension.
Ayodele OE; Alebiosu CO; Salako BL; Awoden OG; Abigun AD
Cardiovasc J S Afr; 2005; 16(2):89-93. PubMed ID: 15915275
[TBL] [Abstract][Full Text] [Related]
10. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
11. Aortic-flow propagation velocity is associated with proteinuria and left ventricular hypertrophy in newly diagnosed hypertensive patients.
Tosun V; Güntekin Ü; Şimşek H; Kandemir YB
Echocardiography; 2019 Feb; 36(2):328-335. PubMed ID: 30605931
[TBL] [Abstract][Full Text] [Related]
12. Is hypertension a prothrombotic state?
Varughese GI; Lip GY
Curr Hypertens Rep; 2005 Jun; 7(3):168-73. PubMed ID: 15913489
[TBL] [Abstract][Full Text] [Related]
13. Creatinine clearance and signs of end-organ damage in primary hypertension.
Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Tomolillo C; Deferrari G; Pontremoli R
J Hum Hypertens; 2004 Jul; 18(7):511-6. PubMed ID: 15002001
[TBL] [Abstract][Full Text] [Related]
14. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
[TBL] [Abstract][Full Text] [Related]
15. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
16. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension.
Saitoh M; Matsuo K; Nomoto S; Kondoh T; Yanagawa T; Katoh Y; Hasegawa K
Intern Med; 1998 Jul; 37(7):576-80. PubMed ID: 9711882
[TBL] [Abstract][Full Text] [Related]
17. Association of renal resistive index with target organ damage in essential hypertension.
Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
[TBL] [Abstract][Full Text] [Related]
18. Mild renal dysfunction and cardiovascular risk in hypertensive patients.
Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Deferrari G; Pontremoli R
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S88-90. PubMed ID: 14684681
[TBL] [Abstract][Full Text] [Related]
19. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
20. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
